NCCM
KYNB

Nine Chapters Capital Management’s Kyntra Bio KYNB Stock Holding History

Nine Chapters Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-456
Closed -$250K – 194
2015
Q3 		$250K Sell
456
-56
-11% -$33.9K 0.02% 769
2015
Q2 		$301K Buy
+512
New +$298K 0.03% 717

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nine Chapters Capital Management's KYNB Position: Q4 2015 in Review

Nine Chapters Capital Management sold out of Kyntra Bio (KYNB) in Q4 2015, closing a stake of 456 shares — an estimated $250K sold.

Nine Chapters Capital Management first reported a position in KYNB in Q2 2015 and held it in 2 quarters. The position peaked at $301K in Q2 2015. 134 funds tracked by Wall St. Rank hold KYNB as of Q4 2015.

  • Nine Chapters Capital Management reported no remaining Kyntra Bio position as of Q4 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 456 Kyntra Bio shares in Q4 2015, an estimated $250K.
  • Nine Chapters Capital Management first reported a position in Kyntra Bio in Q2 2015 and held it in 2 quarters.
  • Nine Chapters Capital Management's Kyntra Bio position peaked at $301K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2015.

Based on Nine Chapters Capital Management's 13F filing for Q4 2015.